Groundbreaking Phase 3 Trial Targets Deadly H5N1 Influenza
A critical phase 3 clinical trial is testing the effectiveness of an mRNA vaccine against H5N1 influenza, a highly dangerous strain currently raising alarms worldwide. This virus predominantly infects birds but occasionally jumps to humans with often fatal consequences. Scientists warn that if H5N1 mutates to spread easily between people, it could trigger a swift and devastating pandemic.
In the wake of the COVID-19 crisis, governments are fiercely committed to bolstering global defenses against future viral threats. The innovative mRNA vaccine under development offers the promise of rapid, large-scale deployment should H5N1 escalate into a widespread outbreak.
John Tregoning, Professor of Vaccine Immunology at Imperial College London and author of Infectious: Pathogens and How We Fight Them, explains how mRNA technology could revolutionize pandemic preparedness and response strategies.
Honoring Sir David Attenborough with a Scientific Discovery
As the world eagerly anticipates the 100th birthday of legendary broadcaster and behavioural ecologist Sir David Attenborough, Inside Science highlights a remarkable species named in his honor. This week, Dr. Frankie Dunn reveals her discovery of the earliest known animal predator fossil, shedding new light on the origins of complex life.
Science News You Can’t Afford to Miss
Lizzy Gibney, senior reporter at Nature, uncovers the latest scientific breakthroughs that have flown under the radar but hold immense significance for our understanding of the natural world.
